期刊文献+

2015年—2020年温州市新报告HIV/AIDS病例首次CD4^(+)T淋巴细胞检测结果分析 被引量:4

Analysis of the first CD4^(+)T lymphocytes test results of newly reported HIV/AIDS cases in Wenzhou City during 2015-2020
原文传递
导出
摘要 目的了解温州市2015年—2020年新报告HIV/AIDS病例首次CD4;T淋巴细胞(简称CD4细胞)水平,评估免疫状况和疾病进展,为艾滋病防治提供科学依据。方法从艾滋病综合防治数据信息管理系统获得温州市2015年—2020年新报告HIV/AIDS病例信息,对一般人口学特征和首次CD4细胞检测结果进行统计分析。结果2015年—2020年温州市新报告HIV/AIDS病例完成首次CD4细胞检测比例为95.0%,该比例历年无变化(χ^(2)_(趋势)=1.745,P>0.05)。首次CD4检测与确证时间间隔≤14 d占77.9%,构成比呈现逐年上升趋势(χ^(2)_(趋势)=57.096,P<0.001)。首次CD4细胞<200个/μl占36.2%,构成比呈现逐年上升趋势(χ^(2)_(趋势)=4.948,P<0.05)。男性(95%CI:1.292~1.903),40岁~59岁年龄组(95%CI:1.766~4.632)、60岁及以上年龄组(95%CI:1.395~3.760),医疗机构检测发现(95%CI:1.637~2.342)的HIV/AIDS易发生首次CD4细胞<200个/μl的情况。结论温州市近几年新报告HIV/AIDS病例首次CD4细胞<200个/μl比例较高,且呈现上升趋势,应加强HIV检测覆盖面,尽早发现HIV感染者并启动抗病毒治疗。 Objective To understand the level of the first CD4^(+)T lymphocytes of newly reported HIV/AIDS cases in Wenzhou City during 2015-2020,assess the immune status and disease progression,and provide scientific basis for AIDS prevention and control.Methods Data of newly reported HIV infected persons were collected from HIV/AIDS Prevention and Control Information Management System.General demographic characteristics and the first CD4^(+)T lymphocytes were analyzed.Results From2015 to 2020,the proportion of newly reported HIV/AIDS cases in Wenzhou who completed the first CD4^(+)T cell test was95.0%,and this proportion has not changed over the years(χ^(2)_(tendency)=1.745,P>0.05).The time interval between the first CD4^(+)T test and confirmation less than or equal to 14 days accounted for 77.9%,and the proportion showed an upward trend year by year(χ^(2)_(tendency)=57.096,P<0.001).The first CD4^(+)T less than 200 cell perμl accounted for 36.2%,and the proportion showed an upward trend year by year(χ^(2)=4.948,P<0.05).The initial CD4^(+)T cell count test result less than 200 cells perμl was more likely to occur for the patients of male(95%CI:1.292-1.903)in 40-59 age group(95%CI:1.766-4.632),60 and above age group(95%CI:1.395-3.760),and the cases diagnosed from medical institutions(95%CI:1.637-2.342).Conclusion In recent years,the proportion of newly reported HIV/AIDS cases in Wenzhou City for the first CD4^(+)T less than 200 cell perμl is high,and it is showing an upward trend.We should strengthen the coverage of HIV testing,detect HIV-infected persons as soon as possible and initiate antiviral treatment.
作者 金茜 叶振淼 赵丽娜 张鹤美 苏德华 王大勇 JIN Qian;YE Zhen-miao;ZHAO Li-na;ZHANG He-mei;SU De-hua;WANG Da-yong(Wenzhou Municipal Center for Disease Control and Prevention,Wenzhou,Zhejiang 325000,China)
出处 《中国卫生检验杂志》 CAS 2022年第4期457-460,464,共5页 Chinese Journal of Health Laboratory Technology
关键词 艾滋病病毒/艾滋病 CD4^(+)T淋巴细胞 检测 HIV/AIDS CD4^(+)T Lymphocytes Detection
  • 相关文献

参考文献14

二级参考文献130

  • 1李楠,缪礼锋.WB带型分析对HIV感染期和AIDS期的诊断意义[J].疾病控制杂志,2005,9(4):376-377. 被引量:46
  • 2李燕,梁彩云,高凯,顾菁,徐慧芳.265例HIV-1抗体阳性者抗体蛋白印迹带型分析[J].中国公共卫生,2005,21(11):1293-1294. 被引量:21
  • 3中国疾病预防控制中心.全国艾滋病检测技术规范(2009修订版)[S].2009-11-30.
  • 4张景祥,徐振源,吴有炜,唐旭清.CD_4细胞与艾滋病治疗免疫评价的研究[J].疾病控制杂志,2007,11(4):339-341. 被引量:20
  • 5U. S. Public Health Service(USPHS) and Infectious Disease Society of America( IDSA). 2001 USPHA/IDSA guidelines for the prevention of opportunistic infected with human immunodeficiency virus [ J ].MMWR,2001,1 - 68.
  • 6Burman W, El-Sadr WE, Matts J, et al. Continued low rates of Mycobacterium avium complex and bacterial pneumonia despite withdrawal of azithromycin prophylaxis among patients with CD4^+ cell rebound[A]. Program and abstracts of the 9th Conference on Retroviruses and Opportunictic Infections [ C]. Seattle, Washington, February 24 -28,2002,631.
  • 7Yangco BG, Von Bargen JC, Moorman AC, et al. Can PCP prophylaxis be safely discontinued among clinically improving HIV patients[ C] ?[ Abstract I - 262 ]. 38th ICAAC, San Diego, CA, 1998.
  • 8Anglaret X, Chene G, Attia A, et al Early chemotherapy with trimethoprin-sulphamethoxazole for HIV-1 infected adults in Abidjan,Cote d' Ivoire: a randomised control trial[J ]. Lancet, 1999,353:1463-1468.
  • 9Wiktor SZ Morokro MS, Grant AD, et al. Efficacy of trimethoprin-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-linfected patients with tuberculosis in Adidjan, Cote d' Ivoire: a randomised control trial [J ]. Lancetl, 999,353:1469 - 1474.
  • 10Mellors JW, Munoz A, Giogi TV. et al. Plasm viral load and CD4^+ lymphacytes as prognostic markers of HIV-1 infection[J ]. Ann Intern Med,1997,126:946- 954.

共引文献294

同被引文献46

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部